Celebrating Five Years of Impact at MIP
Milestones are important and that’s why we are thrilled to celebrate five years at MedTech Impact Partners! We couldn’t have grown to this point without the wonderful support of our global network of partners and outstanding clients.
Where We Are…
We have expanded into 4 of the top MedTech markets, globally.
Where We Are.
Our clients are a cross-section of the MedTech ecosystem. They range from venture capital firms to startups, large corporations and law firms.
Our efficient process uses more than 15 standard tools that accelerate Food and Drug Administration (FDA) application review; making it worth your time to Talk to the FDA before You Talk to the FDA.
MIP’s proven performance and valuable research collaborations have positioned us at the forefront of a rapidly changing medtech landscape.
Our managing partner, Kwame Ulmer, worked with colleagues at UCLA to bring up-to-date information and supporting data for future innovators in the recently published report: Interstates and Autobahns: Global Medtech Innovation and Regulation in the Digital Age.
Looking Back.
In 2017, when Kwame Ulmer founded Ulmer Ventures, his top goal was to provide premium and expert-driven solutions to innovators working to get world-class technology to market faster in the United States.
Over the last few years, Ulmer’s vision grew to encompass a suite of services that helps partners around the world address healthcare innovation. In 2022, Ulmer rebranded his company as MedTech Impact Partners (MIP) to reflect that change.
Where We’re Headed.
As we work towards future milestones, MIP will continue to focus on our mission to help all partners in the MedTech ecosystem by prioritizing a commitment to data-driven research, providing valuable industry insights and through our philanthropic work that will give more innovators a stepping stone to enter the landscape
Our team is scheduling discovery meetings to learn more about your organization and goals. If you’re interested in learning more, please contact us, here.